Table 4.

The results of QoL assessment (EORTC QLQ-C30 symptom scales) in patient groups differing with respect to the level of illness acceptance and the results of the analysis of variance.

QLQ-C30 Symptom Scales	Level of Illness Acceptance (AIS)			ANOVA p
	Low Acceptance 8–18 pts.	Moderate Acceptance 19–29 pts.	High Acceptance 30–40 pts.
	n = 32	n = 69	n = 101
Fatigue (FA)				<0.001
M ± SD	51.0 ± 21.5	42.7 ± 21.4	34.3 ± 21.0
Me (Q1; Q3)	44 [33; 67]	33 [33; 56]	33 [22; 44]
Min–Max	11–100	0–100	0–100
Nausea and vomiting (NV)				<0.001
M ± SD	35.9 ± 36.4	17.1 ± 24.6	6.4 ± 17.8
Me (Q1; Q3)	33 [0; 67]	0 [0; 33]	0 [0; 0]
Min–Max	0–100	0–100	0–100
Pain (PA)				<0.001
M ± SD	44.8 ± 24.5	31.2 ± 24.9	21.1 ± 23.0
Me (Q1; Q3)	50 [33; 67]	33 [17; 50]	17 [0; 33]
Min–Max	0–100	0–100	0–100
Dyspnoea (DY)				<0.001
M ± SD	34.4 ± 35.4	10.8 ± 23.4	10.6 ± 20.0
Me (Q1; Q3)	33 [0; 67]	0 [0; 0]	0 [0; 0]
Min–Max	0–100	0–100	0–67
Sleep disturbance (SL)				0.278
M ± SD	46.9 ± 31.5	42.6 ± 33.0	37.0 ± 34.3
Me (Q1; Q3)	67 [33; 67]	33 [33; 67]	33 [0; 67]
Min–Max	0–100	0–100	0–100
Appetite loss (AP)				<0.001
M ± SD	40.6 ± 31.4	24.2 ± 28.5	12.2 ± 22.5
Me (Q1; Q3)	33 [0; 67]	33 [0; 33]	0 [0; 33]
Min–Max	0–100	0–100	0–100
Constipation (CO)				0.001
M ± SD	31.2 ± 31.6	24.6 ± 19.5	14.9 ± 24.3
Me (Q1; Q3)	33 [0; 67]	33 [0; 33]	0 [0; 33]
Min–Max	0–100	0–67	0–100
Diarrhoea (DI)				<0.001
M ± SD	35.4 ± 33.8	6.3 ± 15.4	6.3 ± 17.5
Me (Q1; Q3)	33 [0; 67]	0 [0; 0]	0 [0; 0]
Min–Max	0–100	0–67	0–100
Financial difficulties (FI)				<0.001
M ± SD	45.8 ± 32.5	33.3 ± 28.0	22.7 ± 28.4
Me (Q1; Q3)	33 [33; 67]	33 [0; 33]	0 [0; 33]
Min–Max	0–100	0–100	0–100

M—mean; SD—standard deviation; Me—median; Q₁—lower quartile; Q₃—upper quartile; Min—lowest value; Max—highest value; n—number; values in bold indicate statistical significance (p < 0.05).